Exact(1)
14 The RR, median OS, and median PFS associated with nab-paclitaxel plus GEM were 23%, 8.5, and 5.5 months, respectively, indicating that this may represent another prospective regimen for patients with MPC.
Similar(59)
Although all patients were treated with sorafenib according to a prospectively designed regimen, the study was not designed as a prospective phase II trial.
The prospective follow-up regimen consisted of standardized clinical as well as radiological evaluations preoperatively, 12 months and 24 months postoperatively.
Prospective studies comparing regimens are needed to confirm this finding and determine the optimal approach to patients who are eligible for either MA or RIC/NMA conditioning.
Evidence for this regimen includes prospective randomized trials demonstrating the efficacy of cimetidine in healing ulcers after acid-reducing operations and prospective, randomized studies documenting the efficacy of histamine-2 receptor antagonists and protein pump inhibitors in the management of patients with primary PUD.
1) To determine the pharmacokinetics of tramadol hydrochloride and its active metabolite, O-desmethyltramadol (M1), after administration through different routes in female and male C57Bl/6 mice; 2) to evaluate the stability of tramadol solutions; and 3) to identify a suitable dose regimen for prospective clinical analgesia in B6 mice.
Prospective evaluation of this regimen in specific trials on elderly MPM patients is warranted.
These preliminary results are of considerable interest and suggest that prospective evaluation of this regimen is warranted in patients with this condition.
neutropenia *The literature was selected according to the criteria as follows: (1) NSCLC patients with previously untreated with chemotherapy; (2) treated with irinotecan-based doublet regimen; (3) prospective clinical trials Phase II and III.
The selected criteria were as follows: (1) NSCLC patients with previously untreated with chemotherapy; (2) treated with irinotecan-based doublet regimen; (3) prospective clinical trials Phase II and III.
These findings will help guide prospective design of sampling regimens, or, when sample size cannot be increased, will aid investigators in understanding the limitations of ML estimates of k̂ and associated CIs.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com